Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

849 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.
Ruggenenti P, Perico N, Gotti E, Cravedi P, D'Agati V, Gagliardini E, Abbate M, Gaspari F, Cattaneo D, Noris M, Casiraghi F, Todeschini M, Cugini D, Conti S, Remuzzi G. Ruggenenti P, et al. Among authors: conti s. Transplantation. 2007 Oct 27;84(8):956-64. doi: 10.1097/01.tp.0000284808.28353.2c. Transplantation. 2007. PMID: 17989600 Clinical Trial.
Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.
Ruggenenti P, Cravedi P, Sghirlanzoni MC, Gagliardini E, Conti S, Gaspari F, Marchetti G, Abbate M, Remuzzi G. Ruggenenti P, et al. Among authors: conti s. Clin J Am Soc Nephrol. 2008 Nov;3(6):1652-9. doi: 10.2215/CJN.01730408. Epub 2008 Aug 6. Clin J Am Soc Nephrol. 2008. PMID: 18684896 Free PMC article. Clinical Trial.
Disruption of the Ang II type 1 receptor promotes longevity in mice.
Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G. Benigni A, et al. Among authors: conti s. J Clin Invest. 2009 Mar;119(3):524-30. doi: 10.1172/JCI36703. Epub 2009 Feb 9. J Clin Invest. 2009. PMID: 19197138 Free PMC article.
Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.
Gagliardini E, Corna D, Zoja C, Sangalli F, Carrara F, Rossi M, Conti S, Rottoli D, Longaretti L, Remuzzi A, Remuzzi G, Benigni A. Gagliardini E, et al. Among authors: conti s. Am J Physiol Renal Physiol. 2009 Nov;297(5):F1448-56. doi: 10.1152/ajprenal.00340.2009. Epub 2009 Aug 12. Am J Physiol Renal Physiol. 2009. PMID: 19675181 Free article.
849 results